Cargando…
Incidence in pharmacoepidemiology: A conceptual framework for incidence of a single substance or group of substances with statins as an example
A framework for analysing incidence in pharmacoepidemiology and drug statistics is suggested using statins as an example. A new case of statin use (first‐ever use or recurrence of treatment) can be defined as new on the group (NoG), new on substance whether new on the group or not (NoS), new on subs...
Autores principales: | Hoffmann, Mikael, Støvring, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107903/ https://www.ncbi.nlm.nih.gov/pubmed/36414232 http://dx.doi.org/10.1111/bcpt.13816 |
Ejemplares similares
-
Incidence in pharmacoepidemiology—Basic definitions and types of misclassification
por: Hoffmann, Mikael, et al.
Publicado: (2022) -
A new likelihood model for analyses of pharmacoepidemiologic case–control studies which avoids decision rules for determining latent exposure status
por: Støvring, Henrik, et al.
Publicado: (2021) -
A new approach of nonparametric estimation of incidence and lifetime risk based on birth rates and incident events
por: Støvring, Henrik, et al.
Publicado: (2007) -
Longitudinal pharmacoepidemiological and health services research for substance users in treatment: protocol of the Belgian TDI-IMA linkage
por: Van Baelen, Luk, et al.
Publicado: (2018) -
Annual incidence of substance-induced psychoses in Scandinavia from 2000 to 2016
por: Rognli, Eline Borger, et al.
Publicado: (2023)